Amsterdam

• A phase 3 study to evaluate petosemtamab plus pembrolizumab vs pembrolizumab in first-line treatment of head and neck cancer Recruiting
  2023-510323-30-00 5 2025-01-24 First-line treatment of recurrent or metastatic PD-L1+ head and neck s
• Revised dosing of Ciprofloxacin for patients with impaired renal function: a bioequivalence study Recruiting
  2024-520379-28-00 6 2025-01-24 bacterial infection
• A first-in-human study to determine the safety and tolerability of different doses of GEH200520 Injection and GEH200521 (18F) Injection and … Recruiting
  2024-515218-42-00 1 2025-01-23 Irresectable or metastatic solid tumour or a local and resectable head
• HiPRESS study Recruiting
  2024-513598-33-00 6 2025-01-21 Disseminated cancer
• Amivantamab + Chemotherapy Versus Cetuximab + Chemotherapy in Treatment-naïve Participants with KRAS/NRAS and BRAF Wild-type Colorectal Canc … Recruiting
  2024-513852-13-00 5 2025-01-20 KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Col
• Colchicine for the treatment of hip and knee osteoarthritis. Recruiting
  2024-511359-16-00 5 2025-01-17 Osteoarthritis
• A study to evaluate the efficacy and safety of frexalimab, brivekimig or rilzabrutinib in participants aged 16 to 75 years with primary foca … Recruiting
  2024-511775-15-00 4 2025-01-17 Immune system diseases
• Phase II randomized study evaluating a Pragmatic approach to Adoptive Cell Therapy (ACT) using an IL2 analog (ANV419) vs High dose IL2 after … Recruiting
  2023-506400-99-00 4 2025-01-15 Advanced selected solid tumors: melanoma, non-small cell lung cancer (
• BuLLSEYE Recruiting
  2024-512950-13-00 11 2025-01-03 Sepsis
• The effect of a booster vaccination on protection against the mpox virus: is a booster vaccination with a lower dose as effective as the sta … Recruiting
  2024-510697-24-00 10 2025-01-02 mpox (earlier: monkey pox)
• Studying the effects of deferiprone in Pelizaeus-Merzbacher disease Recruiting
  2024-511968-81-00 4 2024-12-27 Pelizaeus-Merzbacher disease
• Efficacy and Safety of Anitocabtagene Autoleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Multiple Myeloma Recruiting
  2024-511188-26-00 5 2024-12-20 Relapsed/refractory multiple myeloma in patients who have received 1 t
• Safe Stop Trial Melanoma Recruiting
  2024-516937-10-01 5 2024-12-18 Melanoma
• ChemoRadiotherapy with Or Without surgery followed by consolidation Durvalumab (CROWD): a phase IV feasibility trial Recruiting
  2024-511711-21-00 6 2024-12-16 Stage III non-small cell lung cancer
• [18F]Fluoride PET-CT in psoriasis patients at risk for developing psoriatic arthritis Recruiting
  2024-514759-13-01 4 2024-12-16 Psoriasis
• A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared … Recruiting
  2023-504022-19-01 5 2024-12-13 Polymyositis or dermatomyositis according to 2017 EULAR / ACR classifi
• The detection of tumor-associated fibrosis in colorectal peritoneal metastases by FAPI-PET (TROMPET) Recruiting
  2024-512301-16-01 3 2024-12-12 Metastatic colorectal cancer
• A Study to Assess Distribution, Binding, and Retention of the Monoclonal Antibody Trontinemab in the Brain of Healthy Participants and Patie … Recruiting
  2023-509900-14-00 3 2024-12-10 Alzheimer’s Disease (AD)
• A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injection in Subject … Recruiting
  2024-513860-25-00 9 2024-12-10 Ovarian Neoplasms
• Positron emission tomography with macrophage targeting to select individuals at risk for rheumatoid arthritis. Recruiting
  2024-513538-40-02 4 2024-12-09 ACPA positive arthralgia
• Stopping or continuing blood thinners after stroke at young age without a known cause: STOP trial Recruiting
  2024-513092-40-00 6 2024-12-05 Stroke
• This is a study to evaluate safety and efficacy of Upadacitinib comparing to Dupilumab in children from 2 to less than 12 years of age with … Recruiting
  2023-504713-76-00 5 2024-12-03 Dermatitis atopic
• Ulipristal versus surgery for symptomatic uterine fibroids Recruiting
  2024-512602-26-00 6 2024-12-02 Uterine fibroids
• Tau PET imaging in cognitively normal elderly subjects: A twin approach Recruiting
  2024-517634-17-01 4 2024-12-02 Healthy controls (investigating preclinical Alzheimer's Disease)

Showing 385–408 of 1,112 trials